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SUMMARY.-The growth of an allogeneic rapidly growing and metastasizing
sarcoma (P-388) in the rat is described. Quantitative and kinetic data are
provided concerning the growth of individual metastases produced in three
principalregionallymph node drainage groups, and are compared withgrowth
of the primary tumour of origin in muscle; the incidence of pulmonary meta-
stases is also given. The effects on growth of metastases and primaries pro-
duced by sublethal whole body irradiation (WBI) before inoculations of 10-108
tumour cells are described.
Growth of P-388 sarcoma in unirradiated recipients (ED50
- 5 X 10,3 cells)
obeyed the linear growth law proposed by the Mayneord model for tumour
growth, but in irradiated recipients (ED50 <10 cells) early growth ofprimaries
and metastases approximated more closely to an exponential rate of growth.
The ratio M/P of weight of metastases (M) to weight of primary tumour of
origin (P) increased at a linear rate with age (t) of tumour, and gave the same
slope namely, 0-029 for pelvic node metastases) in unirradiated rats inoculated
with a large (106-107) number of cells as in irradiated rats. The slope was
decreased to 0-014 for pelvic node metastases in unirradiated rats challenged
with fewer(104) cells but not in irradiated recipients. It is postulated that the
effects of WBI on growth of metastases are confined to causing a suppression of
immunity, and that WBI does not affect tumour spread significantly through
other mechanisms.
In immunologically competent rats the phenomena of sequestrated pro-
gressive growth of isolated metastases in lymph nodes and of a chronic non-
progressive enlargement of nodes in which persistent tumour growth and
destruction occurred side by side are described, and effects on prognoses and
clinical behaviour, are discussed.
The P-388 tumour is considered of value in quantitative and kinetic experi-
mental studies of metastases, and particularly those in which the role of
immunity needs to be assessed and measured to avoid confusion with other
factors or agents which might affect the spread and growth of metastases.
RELATrVELY fewtransplantable solid tumours in animals metastasizeregularly from the primary site ofinoculation and allow comparative and kinetic studies of
growth of metastases to be made. This paper documents quantitative data con-
cerning the rates ofgrowth of solid metastases in lymph nodes and lungs from a
rapidly growing allogeneic sarcoma P-388 in the rat, alid compares growth in un-
irradiated (immunologically intact) recipients with gro-wth in rats given sublethal
whole body irradiation before tumour inoculations to suppress the immunological reactions to tumour growth.187 GROWTH OF METASTASES FOLLOWING IRRADIATION
MATERLkLS AND METHODS
Tumour
The P-388 sarcoma used in theseexperiments was anitrogen-mustarcl resistant
strain ofYoshida ascites sarcoma, which waskindlyprovidedbyDr. T. A.Connors,
Chester Beatty Institute, Lonclon.
The original Yoshida sarcoma could be grown either as an ascitic or solid
tumour and was considered to be ofreticulo-endothelial derivation (Yoshicla, 1949,
1952). The P-388 variantbehavessimflarlyandresembles ananaplasticreticulosis
in its mode ofgrowth and spread. The tumour metastasizes freely and rapidly
along associatedlymphaticpathways to form metastaticdeposits inregionallymph
nodes. At a later stage centripetal lymphatic spread produces more widespread
node metastases. Tumour cells which enter the mainlymphatic ducts are carried
into the venous circulation, traverse the right heart and arrest in the lungs to
produce discretepulmonary metastases. Largersoliddeposits oftumour-both at
the primary site and metastases-are characterized by an outer narrow rapidly
proliferating and invasive zone, an intermecliate intensely haemorrhagic zone
consisting ofboth viable andnecrotic foci oftumourseparatedbylakes ofstagnant
blood andhaemorrhage, and a central zone ofnecrotic tumourwhichpredominates
in larger older tumours. Thus in structure the P-388 tumour conforms with the
model system of tumourgrowth proposedbyMayneord (1932). Histological and
micro-angiographic studies have shown that this tumour fails to stimulate signifi-
cantgrowth ofnewbloodvessels(angiogenesis) andothertissueswhich constitute a
vascular stromarequired to support its continuedgrowth and to prevent necrosis
(tobepublished); viableprohferatingtumourprimarilyutilizesthecapillarybedsof
the invaded tissues for its nutrition and metabolism. Intratumoral haemorrhage
causes growing soliddeposits to be blood-red in colour and this facilitates the enu-
merationofpulmonarymetastasesinfreshlyexcisedlungsforquantitativepurposes.
Passage and inoculation
The P-388 tumour was passaged every 4.4 days in female Caworth Farm
(Wistar) rats of a specific pathogen free strain by intraperitoneal inoculation of
1-2 x 106 P-388 cells. Suitably diluted tumour ascites fluid was counted in a
Coulter (model A) electronic cell counter. A parallel differential count oftumour
cells anderythrocytes was made on each donorsample to correct for contamination
with blood. In samples of 4=5-day-old ascites fluid used for inoculation, < 5%
oferythrocytes and <1% ofleucocytes andmacrophages wereusuaRy present and
tests for cell viabihty based on a dye-exclusion technique with 0-1% nigrosin showed that < 0-I% tumour cells appeared non-viable.
P-388 ascitesfluid was dilutedwithice coldTyrode'sbuffer(pH 7
-6), and 0-I ml.
containing the required number of cells was inoculated intramuscularly into the
distal third ofthegastrocnemius muscle above the anklejoint ofthe rat. A group of 6-8 rats were used for each point in constructing tumour growth curves.
Tumour inoculations made into the leg muscle of rats gave rise to diffuse
thickenings whichexpanded theleg into apyramidalshape. Theusing ofcalipers
to determine mean dimensions was found both tedious and inaccurate. Con-
sequentlygrowth oftumour in theleg was scored at 1-2day intervals in individual
rats which were randomized, using a semi-quantitative index of the size (0-6) graded as: no tumourpalpable (0); slightthickening (1); spindleshapedthickening188 H. A. S. VAN DEN BRENK ET AL.
ofdistal ofleg muscle but no visible deformity (2); whole calfthickened, with
visibleenlargement andencroaching onpophteal fossa (3);largetriangularshaped
tumefaction of whole calf and thigh muscle causing flexion deformity (4); and
whole hindquarter involved bv larLye tumour with oedema offoot (6).
Toweighprimary tumour and metastases, the rat was killedby an overdose of
pentobarbital Na and dissected. The ipsilateral (inoculated side) and contra-
lateralpopliteal nodes were removedthroughlongitudinal incisions over each fossa
and weighed. Then both hind limbs were amputated at the same level and
weighed separately to determine weight of the primary tumour by subtraction.
To calculate the error involvedinexcising andweighing afimb, theright hindlimb
was excised in groups ofsix normalrats,weighing 100-120 g., and the meanweight
oflimb per unit body weight determined. The latter was found to be associated
with a standard deviation of ± 5%, and it was calculated that a difference in
weight of not less than 0-6 g. between the intact and tumour-bearing legs was
required to besignificant at the 0-05 level. Next, the abdomino-thoracie skin was
incised longitudinally, widely elevated and retracted to expose inguinal, axillary
and submandibular nodes on both sides. Anymacroscopic evidence ofmetastases
was recorded, and in some experiments the inguinal nodes were removed and
weighed. The abdomen wasopened, and thevagina and rectum divided as low as
possible; the uterus and adnexa, and rectum were stripped to expose the central
groups of lower and upper abdominal nodes which were removed and weighed.
The lower abdominal nodes (referred to as the
"pelvic
" group) were defined as all
nodes contained within the bifurcation of the aorta (presacral and iliac nodes)
together with all paraortic nodes distal to the renal vessels, but excluding nodes
contained within the leaves of the mesentery and mesocolon. The
" upper abdominal node
" group was constitutedby allretroperitonealparaortic and retro-
aortic nodes situated between the origin of the renal vessels and the crura of the
diaphragm, i.e. the nodes related to the coeliac axis and the origin ofthe thoracic
duct, including the retroaortic node which is partly hidden by the left crus of the
diaphragm. Lymphatic dissemination of the tumour from the primary inocula-
tion site in the leg involved early spread to ipsilateral popliteal (crural (CN)) and
pelvic nodes, followed by subsequent spread to upper abdominal nodes, inguinal and mesenteric nodes. Once upper abdominal node metastases were present, and
often earlier, a more widespread dissemination oftumour to more outlying lymph node groups (mediastinal and thymic groups, axillary and even submandibular
lymphnodes) was seen. In animals with advancedtumours, andparticularly after
wholebodyirradiation, the contralateralinguinalnodes and contra-lateralpopliteal nodes became macroscopically involved andenlarged. The number ofmetastases
present on the pleural surface-s ofbothlungs were counted when their number clid
notexceed 200. Iinlungswith 200 or morepleural metastases it was notpossible to
makesufficientlyreliablecounts, andthese rats were scoredarbitrarily ashaving 200
(maximum) metastases. Inmostexperimentsthespleenandthymus wereremoved
and weighed, and individual changes in body weight of rats were also recorded.
The weights of the primary tumour in the leg (P) ipsilateral popliteal nodes
(CN), pelvic nodes (PN) and upper abdominal nodes (UAN), respectivelv were used
to construct corresponding growth curves. The incidence of pulmonary meta-
stases largely represented the
" final spill-over
" oftumour metastasis in the lym- phatic system into the circulation. The correspondingweights ofprimary tumour
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and relative rates ofgrowthbydeterminingchanges in the ratioM/P with time (T)
after inoculation, or by altering the number (N) of tumour cells inoculated and
weighing the tumours at the same POSt-iDoculation time. In uninoculated rats
the normal weights of pelvic, upper abdominal and crural lvm-ph nodes were
<0-04) <0-03, and < 0-01 g. respectively in unirradiated rats and <0-02,
< 0-01 and < 0-005 g. respectively after 570 rad. WBI. To calculate M/P ratios,
the maxiMum weights of normal lymph nodes were subtracted from weights of
corresponding involved nodes in the inoculated rat to obtairl more accurate values
for weight of tumour metastases. In unirradiated rats reactive enlargement of
nodes must also be taken into account. It was found that the injection on three
successive days of 1-5 x 107 P-388 cells subjected to a high dose (4-6krad.)
X-radiation in vitro to prevent their growth (HR cells) did not cause the regional
nodes to increase to more than double their normalweight. Nodesweighing more
than 0-08 (PN), 0-06 (UAN) and 0-02 (CN) g. respectivelyiDunirradiated rats, or
more than 0-02 (PN), 0-01 (UAN) and 0-01 (CN) g. in irradiated recipients invari-
ably showed macroscopic and microscopic evidence of tumour growth, and these
values were taken torepresent the upperlimits ofnormality even in the presence of
reactive (hyperplastic) changes.
Irradiation techniques
A twin-headed therapeutic Cobalt 60 unit, kindly made available by Dr. 1.
Churchill-Davidson, was used to irradiate uniformly a box containing 10-12 rats
placed midv.ay between the two sources. The mean dose rate in tissue from the
two sources (totalling 8273 Ci) was 157 rad. min-'. The rats received a single
whole body exposure of 570 rad. to suppress immunological functions, usually
1-4 hours before inoculation of P-388 cells, but in some experiments 4-16 hours
elapsedbetween irradiation andinoculation. Tw'mopposedX-raybeamsoperated
at 250 kv 15MAwith added filtration to give a HVL I
-0 mm. Cu were used to
irradiate tumour cells in vitro and also to locally irradiate the limb tumour, the
body of the anaesthetized animal being shielded between 2 mm. thick lead plates
containing appropriate cutouts to expose the tumour bearing hmb tissues only.
Tumour
" take
" andED50
The number ofP-388 cellsrequired toproducepalpable (Grade 1-2) tumours at
the site ofprimary inoculation in muscle within 4 weeks afterinoculation in 50% of
rats was taken to represent the ED.50 dose.
Double leg inoculations
In certainexperiments the host'simmunologicalcapacity to react to P-388 cells
was assessed in terms of the growth of a second intramuscular challenge of the
tumour to the contralateral leg (termed second challenge), given at intervals after
the first challenge.
Immunt'zation of rats against P-388 cells
In some experiments, active immunization involved the use of P-388 cells
sterilizedbyheavy irradiation (HR) orby incubation at 37' C. for 30 minutes with
asulphydrylinhibitor, sodiumiodoacetate (NaIOA) orN-ethylmaleimide (NEM) as
described by Apffel et al. (1966). It was found that the P-388 tumour cells were190 H. A. S. VAN DEN BRENIK ET AL.
unusually resistant to killing by these reagents; incubation in concentrations of
10-2m NaIOA and 10-1 m NEM respectively were required to prevent growth of
106-101 tumour cells in rats which had notreceivedwholebodyirradiation. It was
also found that P-388 cells stored frozen at 70' C. in the presence ofglycerol or
dimethylsulphoxide, and irradiated with 4000-6000 rads afterthawing, were much
less effective for immunizing of rats than freshly removed and irradiated cells;
NalOA also proved more efficacious than NEM in thisrespect. Consequently, to
increase immunity irradiated non-frozenfreshly removed cells, orfreshly removed
cells incubated with 10-2m NalOA or 10-1 m NEM, were used. Rats received
1-4 x 107 inactivated P-388 cells subcutaneously twice weekly for 3 weeks, and
were challenged intramuscularly a week later with 105 intact P-388 cells. If the
latter failed to
" take
" and grow, the rats were regarded as hyperimmune and a
further 106-107 viable cells were inoculated and their growth compared with the
growth in unimmunized rats.
RESULTS
ED50values (tumour take)
The ED50 value for intramuscular inoculations was approximately 5 X 103
tumour cells in unirradiated recipients and < 10 cells in rats pre-irradiated with
570 rad. WBI. Repeated assays performed over the preceding year gave ED50
values notsignificantly different from these values. In unirradiatedrecipients 102
cellsrarely
" took
" toproducepalpable tumour ormetastases; 105 cellsinvariably
produced local growth of tumour, but metastases often failed to show up macro-
scopically, whilst 106-107 cells produced metastases which grew and killed most
rats within 3-6 weeks.
For subcutaneous inoculations made into the tissues ofthe neck overlying the
salit,ary glands, ED50 values were similar to those obtained for the intramuscular
route, but values werehigher for subcutaneous inoculations into the foot and tail.
Immunizationproduced by growth of tumour
In rats challenged with the tumourin oneleg, which was either allowed to grow forvarying times or treated with a localsingle dose of 1600 rad. X-rays to arrest its
growth, a second challenge withJ06P-388 cells into the contralateralleg grew less
well depending on the interval elapsing between challenges. Fig. I showsgrowth ofsecondchallenges (106cells) in 72 ratsgiven 0-60days after aprimarychallenge
withJ07 cells. Aprogressive increase in immunity occurredduringgrowth ofthe
firstchallenge, even iftumourgrowth wasprevented orreducedbylocalirradiation
administered before the second challenge was given. Fifty days after rats were
challenged withJ07 cells, and theresulting 7-14-day-old tumours had been irradi-
ated to inhibit theirgrowth so as to allow the rats to survive, a secondchallenge of
106 cells failed to take and grow in the opposite leg.
Curves of tumour growth (unirradiated hosts)
Growth curves for theprimaryleg tumour (Pr) at site ofintramuscular inocula-
tion and for lymph node metastases (PN, UAN, CN) in unirradiated female rats
inoculatedwithJ07 or 104 P-388 cells are shown inFig. 2 and 3respectively. Simi-
lar curvilinear, relationships were obtained for Pr and its metastases in lymphnodes. Tumourgrowth ratescharacteristically decreased as tumoursenlarged, i.e.
the doubling time (T) for tumour mass increased (vide infra). Initially weight of
Pr increased veryrapidly (T < 24 hours) as didweight oflymph nodes infiltrated
with tumour in rats given a large inoculum (107 cells). A smaller inoculum(104
cells)produced a morerapid decline ingrowth rate ofPr thanlargerinocula and an
even more markedreduction inthe rate ofgrowth oflymphnode metastases. The
INTERVAL(DAYS) BETWEEN F(16'cells) AND 2ND(ibcells) CHALLENGE
. (0) o 0) o (2) a (7) & (14) 0 (50)
0 5 10 15 20 25
DAYS AFTER SECOND CHALLENGE
WITH 106cells
FiG. I.-Growth curves for secondchallenges of 106P-388 cells inoculated into the contralateral
leg of female rats (solid lines) at various times after the inoculation of 107 cells in the ipsi- lateralleg. Growthcurvesforsingle(first)challengeswithlO5P-388cellsinunirradiatedrats ( x x) and in rats 2 hours after wholebody irradiation ( x
---- x) are show-n for
comparative purposes. Measurement ofsize oftumour has been based o'n the index (Grades 0-6), as described under Methods. Data is for ten groups, each composed of 6-9 rats.
enlarged lymph nodes produced by smaller inocula showed early microscopic evi-
dence oftumour cellproliferation with the presence oftumour cellclones, butthese
metastases usually failed to progress and survive; 2-3 weeks after inoculation the
popliteal and abdominalnodes in most rats remainedeithermoderatelyenlarged or
hadregressed, despite furthergro*th ofprimary (videinfra). However, in a pro- portion ofanimals tumour continued to grow in a single node or node group after
growth in othernodes had ceasedand oftencompletelyregressed. In such animals
alarge solitary tumour metastasis had notinfrequently grown to 50 g. or more
i
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FIG. 2.-Growth curves for primary P-388 tumour (Pr) and for corresponding metastases in pelvic (PN), upper abdominal (UAN) and ipsilateral crural (CN) lymph nodes produced by the intramuscular inoculation of 107 tumour cells into the right gastrocnemius muscle of
unirradisted female rats. Each point represents mean value for a group of 6 rats; each
standard error shown as avertical line where it exceeds the size ofsymbol. Interruptedlines show correction of curves for inetastases in nodes after subtracting norinal node weights. Closed symbols are used for values obtained in 9 immunized rats pretreated with heavily irradiated (HR) tumour cells or cells incubated in 10-lm NEM in which 104 intact cells subse-
quently failed to take; these rats were killed 7 days after a further intramuscular challenge with 2 X_ 107 intact P-388 cells.
0 0 V Growth in 75 g. rats.
Growth in 130 g. rats.
Growth in 1'90 g. rats.
0 A N V Growth in 9 immunized rats (see above).I I
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weight, and caused local complications such as intestinal or biliary obstruction,
ascites (usually non-malignant) etc., resulting in death. Upper abdominal and
mesenteric groups of nodes, including deposits of tumour in Peyer's patches,
appeared most prone to this
" isolated
" development of tumour. These animals
frequently remained in good health and nutrition and gained weight for several
months in the absence ofsuchcomplicationsdespiteprogressivelocahzedgrowth of
the solitary metastasis. Other apparently normal or moderately enlarged lymph
nodes present in the rat and examined histologically usually showed microscopic
foci of tumour growth at various stages of active proliferation or degeneration.
Thus, largeprimary inocula (106-107 cells) tend to growprogressively and pro-
ducecentripetalspread oftumour andprogressive anaemia andmalnutritionwhich
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FIG. 3.-Growth curves forprimary tumour (Pr) and metastases (PN, UAN andCN) produced by inoculation of 104 P-388 cells into right leg muscle ofunirradiated female rats (90-100 g. body weight). Curve Po.N represents the pooled weights of the three lymph node groups. Correspondixig curves (Pr. andPo.N) shown forgrowth of 107 cells inoculated intolegmuscle.
Symbols as in Fig. 2; 6-8 rats per point.I I I I I I I
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terminate inearly death. SmaHer inocula (104-105-cells)usuallyproduce progres-
sively growing and eventually large primaries, eai.ly,but limitedgrowth oflym-ph
node metastases which subsequently regress and'thereby prolong survival or give
rise to the condition of
" solitary
" progressivelygrowing metastases as described
above. Yet smallerinocula( < 104 cells) usually failtotakeprimarilyandestablish
metastases in unirradiated (immunologicaRy intact) hosts.
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FIG. 4.-Growth curves for primary tumour (interrupted lines) and associated pelvic node
metastases (PN) producedby intramuscular inoculation of 104-107 P-388 cells in female rats.
SymbO18 u8ed: Primary tumours produced by 5 X 105-106 cells (40); 104 cells (0); pelvic node weights associated with tumour
" take
" and growth produced by challenges of
5 x 105-106 cells (,&); 105 Cells (M) and 104 CellS (A) respectively. Individual points for
107 inocula not shown. Each point represents mean values for a group of 3-12 rats. The
symbols & show meanweights ofpelvic nodes in rats inoculated with 104-1011 cells, in which
no priinary tumour developed, growth of the primary was arrested at an early stage (< 14
days) or the primary had regressed spontaneously. Included in this category axe PN node
weights of rats inununized with inactivated P-388 cells and subsequently challenged with
106-107 intact tumour cells., which either grew or failed to
" take
" at the site of inoculation.
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Partial active immunization of rats sterilized with P-388 cells, i.e. heavily
irradiated (HR) cells or cells incubated with sulphydryl inhibitors, caused a
reduction in growth rate of both primary tumours and metastases produced by a
large (107 cell) inoculum (Fig. 2) and a corresponding increase in theED50 dose for
primary take of tumour. Intensive immunization with HR cells, reinforced by
challenges withincreasing numbers ofintact tumourcells, made most rats resistant
to afurtherchallengeof 106-107P-388 cells. Fig. 4 summarizes datafrom various
experiments as curves ofgrowth for pelvic lymph node metastases (corrected for
normal weight of nodes) caused by a range of P-388 cell inocula, and includes
growth of metastases in nodes of rats in which arrest of Pr growth had occurred
spontaneously. This occurred in unimmunized rats challenged witb smaller
inocula and inpartially immunized rats challenged with larger inocula. Data are
also shown for rats in which a progressively growing Pr had produced generalized
growth of metastases but at aninadequate rate to cause death within the first 3-4
weeks; these nodes enlarged rapidly initially but thereafter decreased in size and
gave rise to a state ofresidualnon-progressive (" steady state ") enlargement; the
nodes remained 10-20 fold heavier than normal for prolonged periods and on
microscopic examination showed the presence of tumour cell infiltrates and clones
ofvarious sizes and in variousphases ofproliferation anddegeneration. In rats in
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FIG. 5.-Growth curves for primary tumour and metastases produced by intramuscular
inoculations of 5 x 106 P-388 cells in unirradiated rats and I x 106 P-388 cells in rats
exposed to 570 rad. wholebody irradiation 2 hoursbeforechallengewith tumour. Abbrevia-
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which primary growth was spontaneously arrested, node metastases usually
regressed also, and nodes were restored to near-normal size (spontaneous cure of
metastasis), except when isolated metastases continued to grow, often to massive
size, as described above.
Growth of tumour after whole body irradiation (WBI)
Growth curves forintramuscular inocula andregionallymphnode metastases in
rats exposed to a single dose of 570 rad. (6OCO y-rays) whole body irradiation 24
hours precediDg inoculations are shown in Fig. 5 and 6 and are compared with
growth in unirradiated recipierits. For the first week, the growth curves for Pr
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FiG. 6.-Growth curves for primaries (Pr.) and metastases in lymph nodes in unirradiated
(closed symbols) and irradiated (open symbols), rats inoculated with 106 or 104 P-388 cells; 6 rats perpoint, abbreviations as inFig. 3. Measurementsmade onday 14and onday 16 were
on two groups of 6 and 3 irradiated rats inoculated with 102 cells and 103 cells respectively, 2 hours after 570 rad. whole body irradiation.
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and metastases in unirradiated rats wereessentially similar in form to those obtain-
ed with larger inocula in unirradiated recipients, but due to more rapid growth,
somewhat larger tumours resulted in irradiated recipients. Beyond 7 days the
rate ofgrowth ofPr decreased at a disproportionate rate in irradiated rats and Pr
often decreased in weight when the irradiated rats became terminal and suffered
from severe anaemia, loss of weight and widespread growth ofpulmonary meta-
stases (vide infra). The latter was a principal cause of death during the second
week after inoculations of 104 or more cells in rats given WBI. The terminal
decrease in growth rate and weight oflarger tumours in the irradiated host rat is
attributedt'onutritionalfactors andnottotherecoveryofanimmune or some other
host defence mechanism, since fewer (102-103) cells allowed to grow forlonger pro-
duced equallylarge tumours (Fig. 6), and since no comparable decrease in growth
rate oflymph metastases (smallbycomparison withthecorrespondingPr) occurred
in irradiated rats in which concomitant decreases in growth rate of the larger Pr
had taken place.
The most striking difference in tumour growth between irradiated and un-
irradiatedrecipients was the rate ofgrowth ofmetastasesfollowing the inoculation
offewer(IC4) cells(Fig. 6); irradiation causedlymphnode metastases to appearand
grow much more rapidly and at rates comparable to the primary. This is attri-
buted to the arrest ofimmunological reactions after WBI and the associated de-
crease in theED50value) which allowsgrowth of a veryfewnewlydeposited cells to
occur. The curves forenlargement oflymph nodes in unirradiated rats cross those
in irradiated animals (Fig. 6). This is principally due to atrophy of normal node
tissues produced by WBI but also to the contribution made by hyperplasia to
weight ofnodes in unirradiated rats. The latter is negligible after WBI since the
inoculation of as many as 108HR tumour cells into the muscle of irradiated rats
caused no significant increases in weight of crural and pelvic nodes.
The dose (570 rad.) of WBI used in these experiments allowed > 90% of un-
challenged rats to survive beyond 30 days; during the first 7 days weight of the
spleen andthymus decreased by > 50% and > 80% respectively, and these losses
in organ weight were not reversed during the first 10 days, similar delays being
associated with recovery in changes ofbody weight and anaemia and leucopenia
due to WBI. Thesefindingstogetherwith databased onED,50 determinations and
tumourgrowth ratessuggestthatimmunologicaldefencesremainedseverelyattenu-
ated for at least a week after WBI.
Tumour doubling times
The doubling time for tumour mass (T) was plotted as a function ofweight of
tumour (W). In unirradiatedrecipients inoculatedintramuscularly withJ06 cells
T was linearly related to W by the relationship,
logT
= mlog W + c
where m and c are constants. Data for smaller tumours produced by subcutane-
ousgrowthof 106Yoshida sarcoma cells in the flank ofratsreportedby Hirai-et al.
(1968) and our ow-n data forlarger P-388 tumours from intramuscularinoculations,
were fitted by the same linear relationship (Fig. 7). The slope for growthof 107
cells inoculated into muscle was ofthe same order ofmagnitude as for 106cells, but
104 ceRs gave a much steeper increase in T with growth of tumour. This is attri-198 R. A. S. VAN DEN BRENK ET AL.
buted tothe more efficientdestruction oftumourbyimmunereactions in an animal
challenged with a smallinoculum, which takeslonger to grow to a tumour ofgiven
size, andthereby allows ahigher level ofimmunity to be achieved. Measurements
oftumourdoubling times afterWBI, werenecessarily restricted to smaller inocula
since larger inocula grew and produced extensive metastases, at an early stage,
resulting in nutritional decline andearly death ofrats. Fig. 7 shows changes in T
forgrowth ofPr and PN metastasesproducedby 5 x 103cells in both unirradiated
and irradiated recipients, in an experiment using doinor cells from a single rat.
After WBI Pr and PN both grew at exponential rates (i.e. T constant) until the
primary tumourweighed
, 0-5 g. when T (Pr) increased but the metastases (PN,
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it includes data for growth of 106 Yoshida sarcoma cells inoculated subcutaneously in
flanks published by Hirai et al. (1968) which is shown by closed circles. Figure on right shows doubling times forgrowth ofprimary tumour (Pr.) and pelvic lymph node metastases
(PN) produced by 5 x 103 cells inoculated intramuscularly in unirradiated rats (open symbols) and in irradiated (570 rad. WBI) rats (closed symbols) respectively.
and also UAN andCN) continued to grow atexponential rates while theirweights
were less than that ofthe Pr (i.e. <0-5g.). In unirradiated rats T (PN) increased
more rapidly than T (Pr). This may be due to more efficient immunological de-
struction oftumour cells in the nodesper se, but since immunization due togrowth of tumour in the rat is time dependent (Fig. 1, vide supra) and can cope more
efficiently with fewer tumour cells, these factors may also account in part for this
differeDee. However, it was found that when T was expressed as a function of
time after inoculation (tumour age t) that T (metastasis) increased more rapidly than T (primary). Thus T for both Pr and PN metastases increased at approxi- mately linear rates with time (t) after inoculation of tumour cells according to
T =kit+k2199 GROWTH OF METASTASES FOLLOWING IRRADIATION
whereki andk2are constants-arelationship also fittedby the data ofHirai et al.
(1968) for primary tumours. For 5 x 103 cells inoculated into unirracliated rats
values ofk, were 0-55 (primary) ancl 1-65 (PN metastases);correspondingvaluesfor
m (Texpressed as a function of W) were 0-91 (primary) and 1-65 (PNmetastases).
Primary and metastasis growth relationships
The ratio (M/P) for weight of a lymph node metastasis, corrected for normal
tissueweight (M), toweight oftheprimary tumour oforigin (P) was calculated for
each rat and plotted as a function of age of tumour, for growth ot tumour in un-
irradiated and irradiated recipients M/P increased at a linear rate (Fig. 8). The
rate was somewhat higher for metastases in the more proximally situated pelvic
nodes-a difference possibly due to redistributions in flow oflymph and tumour
cells produced by progressive nodal involvement. The finding that the rate of
increase inM/Pwith age ofprimary tumour was less for a smallinoculum(104cells)
thanforlargeinocula(106-107cells) in unirradiatedrecipients, but not inirradiated
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FIG. 8.-Change in ratio (M/P) of weight of lymph node metastases (corrected for normal
node weights) to weight ofpriinary tumour, during growth of P-388 tumour in unirradiated
and irradiated female rats produced by cell challenges of 104-107 cells. Values ofM/P for
pelvic nodes (PN) and upper abdominal nodes (UAN) calculated separately in each rat.
Each point represents mean value (±SE) for a group of 5-6 rats. The relationship ofM/P to tumour age (T) is essentially linear such that M/P
= a T + b; the same calculated mean
values of a. (PN)
= 0-0295 and a (UAN)
= 0-0235 respectively were obtained in irradiated
recipients given 104 or 106 cells, and the slopes for PN, UAN were the same in unirradiated
recipientsgiven 5 x 106 or 107 cells. In unirradiatedrecipients which received 104 cells, the
rate of increase in M/P with time wa-s significantly less (a (PN)
= 0-0140 and a (UAN) 0-0110 respectively). In 5 experiments, the ratio a (UAN)/& (PN)
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recipients, is of particular significance. It is considered that in this anogeneic
system immunity destroys smaller tumour deposits of more recent origin more
effectively than larger ones, and thereby limits the development and growth of
metastases to agreater extent thangrowth oftheprimary tumour oforigin. After
WBI, slopes forM/Pcorresponding to PNand UAN were not affectedbychange in
the numberofcells inoculated overtherangeJO2-106cells. InFig. 9PNandUAN
A. WB/s7orad. B. NO X-RAY
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FIG. 9.-Data from Fig. 6 for 102-106 inocula in irradiated recipients and 5 X 106-107 inoeUla
in unirradiated recipients respectively has been pooled. Regression lines of the same slope (a) according to the equation (M/P)
= a T + c have been arbitrarily fitted for growth of
pelvic node metastases (PN) in irradiated and unirradiated recipients respectively, and similarly forgrowth oftumour in upper abdominal nodes (UAN). Theregressiom aregiven by:
PN (irradiated recipients) M/P
= 0-029 T-0-100
(unirradiated recipients) M/P
= 0-029 T-0-017
UAN (irradiated recipients) M/P
= 0-017 T-0-075
(unirradiated recipients) M/P
= 0-017 T-0-062
ratios have been pooled for 102--106 cells inoculated in irradiated rats and for
106-107 cells in unirradiated ratsrespectively. The two sets ofdata for irradiated
and uiiirradiated recipients have been fitted by linearrela'tionships with the same
slope, 0-029 (PN) and 0-017 (UAN) respectively. The rate ofincrease in the ratio
M/P with age of tumour provides a useful quantitative approach to the study of
kinetic aspects of'Metastatic dissemination and would seem valuable for determin-
ing the effects ofphysical, chemical and biolo ical.treatments, specifically concern- 9GROWTH OF METASTASES FOLLOWING IRRADIATION 201
ed with the control of such spread. Changes are produced by age and size of
tumour in the contents ofblood, oedema and necrosis and this affects the inter-
pretation ofchanges inM/P-particularlyearly after inoculation whendisparity in
size between Pr and M is greatest and the onset ofhaemorrhage and oedema cause
greater increases inweight of the more advanced primary tumour.
In rats sacrificed 7days afterinoculating 1OZ-2 x 107cells, tumourweights (Pr
andPN, UAN and CN metastases) wereplotted on alog-log scale as a function of
the number (N) of cells inoculated, for unirradiated and irradiated recipients
respectively (Fig. 10). After initial slow increases in tumourweights, the relation-
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ships became linear, beyond
" threshold
" values of N
- 103 (irradiated) and
N
- 105 (unirradiated recipieDts). The slopes of the linear regions for Pr and its
metastases in immunologically suppressed and intact hosts, were calculated and
found to approximate to a common value of 0-308. The difference in N of 2-3log
values between irradiated and unirradiated recipients for the onset of linear
increases in tumour weight, corresponds to the difference in ED50values.
Associated changes in the ratioM/P (7 days), expressed as a function of size of
inoculum (N), were obtained in young femalerecipient rats (90-100 g.bodyweight)
using tumour cells harvested froni a single donor rat (Fig. I1). A very large
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FIG. II.-Showing effects of increase in number of P-388 cells inoculated on (a) ratio M/P for
node metastases (b) body weight of inoculated rats during growth of tumour and (e) weight ofspleen and thymus (expressed per unit body weight) in unirradiated (open symbols) and
irradiated (closed symbols) recipients. Data shown for changes inbodyweight and weights ofspleenandthymus, are confined to 90-100 g. rats which werekilled 8days afterinoculation. Data for M/P pooled from a series ofexperiments on rats varying more widely in age; most
were killed after 7 days but some (given smaller inocula) after 8 days.
challenge dose (, 107 cells) was required to raise the values of M/P for PN and
UAN metastases in unirradiated recipients to equal those in irradiated recipients. This represeDtS the threshold in cell number required to initiate growth in this
tumour host system against which immunological defences mounted by the host
against spread oftumour to the nodes becomes insignificant in the control ofsuch
spread or in reducing the rates of growth of tumour at the primary site and in
related nodes.
Metastase8 to lung8 and other organ8
Lung&-Most rats inoculated with 104 or more P-388 cells developed multiple mac.ro'scopic pulmonary metastases. In lungs with 100 or more enumerated
surface nodules lung weights were increased and as much as three- to four-fold
heavier than normal in terminal rats.203 GROWTH OF METASTASES FOLLOWING IRRADIATION
TABLIF, I.-IncidenceofRats withPulmonaryMetastase8, andNumbersofPulmonary
Metasta8e8Scored in Unirradiated andIrradiatedFemale Rats at VarioU8 Times
after the Intramuscular Inoculation ofP-388 Tumour Cells
WBI
N T (+1 -) I PM
102 8 + 6 6, 20, 4, 8, 6, 20
14 + 6 5, 26, 3 and > 100 (3 rats)
103 8 + 6 14, 8,27,1, 5,37
13 + 6 70, 5 and > 100 (4 rats)
104 7 0
8 + 6 15, 25, 16, 5, 16, 20
10 3 3, 3, 4
10 + 6 10, 27, 14, 15, 39, > 100
I I + 6 > 100 (6 rats)
14 2 2, 17
105 7 3 2, 5, 1
7 + 4 4, 1, 4, 2
8 + 6 107, 161, > 200 (4)
106 4 I 2
7 0
7 + 6 66, 48, 85, 18, 6, 43
10 6 9, 3, 1, 2, 4, 1
9 + 6 > 200 (6 rats)
107 7 3 5, 1, 93
7 4 2, 2, 2, 57
7 + 6 > 200 (6 rats)
Abbreviation8: Number of P-388 cells inoculated N, time (days) after inoculation T, whole body irradiation WBI given 2-24 hours preceding inoculation (+) or omitted (-); number of rats which
developed pulmonary metastases I in each group consisting of 6 rats; number of metastases scored in
lungs of each rat on macroscopic examination of freshly excised lungs or of lungs fixed in Bouin's
fluid PM.
Table I andFig. 10 show the number ofpleural metastases enumerated inlungs of uiiirradiated and irradiated rats inoculated with 102-107 P-388 cells. The
incidence rose with the number of cells inoculated and with time after inoculation
and was much higher after WBI. Both unirradiated and irradiated rats with
pulmonary metastases, showed the presence of tumour cells in ventricular blood
and in irradiated rats with massive pulmonary involvement, tumour cells were
often the commonest nucleated cell present. Pulmonary metastases were absent
or few in number in rats killed with early abdominal lymph node metastases and
onlyappeared inlarge numbers ofrather uniform size after morewidespread meta-
stases inlymph nodes had occurred andirrespective ofsize attainedbytheprimary
tumour. Fig. 10 shows that whole body irradiation reduced the number of
inoculated cells required to produce an arbitrarily selected mean incidence of 50
pulmonary metastases in ratsbyapproximately 2-5log values-a difference similar
to that for ED50 values in irradiated and unirradiated rats. Approximately 106
cellsinunirradiated, and 103.__104 cellsinirradiated ratsinducedthe samenumberof
pulmonary metastases. This suggests that irradiation causes a similar degree of
immunological attenuation in thelungs as in other tissues (primary site andlym'ph nodes), and that the incidence oflung metastases simply represents the degree of
cc spill over
" of tumour from thelymphatic system into the circulation andlungs. Heart andkidneylo.-Rats with advancedlymph node andlung metastases, fie-
quently showed growing metastases in themyocardium, particularly in ventricular204 H. S. A. VAN DEN BRENK ET AL.
musculature. Advanced upper abdominallymph node metastases hadfrequently
invadedadjacentkidneys and other organsby direct infiltration. In rats terminal
with widespread pulmonary metastases, the kidneys (and other organs) also
frequently showedmultiple smallsubcapsular metastases similar to those described
forlungs, and whichappeared to have arisenby exfoliation fromlungdeposits and
haematogenous dissemination.
Spleen anathymus.-Anexample ofthechanges inweight ofspleen andthymus
in unirradiated and irradiated recipients is shown in Fig. I1. Unirradiated
recipients inoculated with 107 tumour cells developed splenomegaly (, 15%
increase in weight) accompanied by decrease (, 40%) in w-eight ofthvmus, and
reduction (, 30%) in the rate of growth of the rat during the first 7-10 days.
WBI (570rad.) caused ,50% decrease in weights ofspleen and thymus respec-
tively and body growth was decreased by
, 25%. Wben rats, after WBI, were
inoculated with P-3S8 cells bodvLyrowth was markedlyaffected, and inoculaof 107
cells caused rats to loseweight at > I g. perday. Irradiated rats showedthe same
pattern ofsplenic enlargement and thymic atrophy due to tumour growth as un-
irradiated rats, the changes being superimposed on the atrophy of these tissues
producedby WBI itself(Fig. II). The cause for these opposite changes in spleen
andthyniusweight is not clear. Thymusatrophy may be due to stress, aside from
irradiation damage, and seems to parallel changes in body weight. Increases in
spleenweight appearslargely due togrowth oftumour in this organ, being propor-
tional to the number of cells inoculated and occurring more rapidly in irradiated
rats; microseopicallv, the spleens showed discrete solid foci of tumour cell growth
presentmainlyinwbitepulp. However, whether tumourgrowth accountsentirely
for the changes in spleen weight has not been determined.
DISCUSSION
Relatively fewallogeneic orsyngeneictransplantable tumours are available for
quantitative experimental investigatioins of metastatic spread (Kim, 1970) and to
the role played by immunological reactions in growth of metastases. Although
several experimental tumours produce metastases these may not develop in a
particular organ with sufficient regularity to study the kinetic relationships
between theirgrowth and that oftheprimary tumour oforigin in the same animal.
P-388 sarcoma, an allogeneic, rapidlygrowing tumour host system in the rat, was
chosen principally to investigate these aspects, since it could be grown as a solid
tumour which metastasized along lymphatic pathways to lymph nodes andlungs,
and the recipient rat showed immunological resistance to tumour growth whicb
could either be suppressed or increased by suitable treatment ofrecipients before
challenge with the tumour. Growth ofthe tumour as an ascites forpassaging also
facilitated accurate enumeration of cells for inoculations and assays.
Byweighing theprimary tumour and individuallymph node metastases associ-
ated with its lymphatic spread in animals killed at various times after inoculation
with aknown number oftumourcells,growth curves were obtainedforprimary and
metastases and compared. The enumeration oflung metastases and increases in
lung weight in such animals provided further measures of metastatic behaviour.
Therapid rate ofgrowth ofP-388 sarcoma and its metastases also allowed suitable
measurements ofgrowth to be made under conditions ofimmunologicalsuppression
by sub-lethal whole body irradiation of the host before significant immunological205 GROWTH OF METASTASES FOLLOWING IRRADIATION
recovery tookplace andtherebyprovided animmunological situation more closely
allied to a sy-ngeneic or autochthonous tumour-host system.
Certain characteristics ofP-388growth intissues, sharedby otherexperimental
tumours, present some difficulties to quantitative studies and the tumour appears
to differ somewhat in form and nutrition, from various spontaneous, and particu-
larly less rapidly growing, cancers in man and animals. Its growth is essentially
infiltrative and fails to stimulate a commensurate growth of stroma from normal
tissues including new vessel formation (angiogenesis) and formation of a tumour
capsule. Consequently, tumournutritionlargely comes todepend onthe resources
ofexisting tissuesbeing invadedby thegrowing tumour. The latter-progressively
destroysnormalcapillaries andbloodvessels inthesesupportive normaltissues and
this causes haemorrhage into the tumour, and oedema. Nutrition and oxygena-
tion become inadequate for tumour growth and rapid tumour necrosis develops.
Inadequate nutrition and progressive necrosis appear largely responsible for the
curvilinear form of tumour growth and for increases in tumour doubling time for
both primary and metastasis. However, incompatibifity between tumour and
host(homograft-reactions) andtheprogressive enhancement ofthese reactions pro-
duced by growth of tumour must also decrease growth rates since doubling times
remain constant for longer in immunologically attenuated (irradiated) hosts.
Mayneord (1932) proposed a dynamic model oftumourgrowth based on data pro-
videdby the Jensen sarcoma in the rat, in which thegrowthpattem wasgoverned
by a linear law (tumour dimensions with time) as opposed to an exponential rela-
tionship, andproliferativegrowth was confined to an outer narrow surface zone of
the tumour. The data obtained by Hirai et al. (1968) for Yoshida sarcoma was
found to fit the Mayneord model, as did our own data for both primary and node
metastases from P-388 sarcoma in unirradiated (immunologically intact) rats.
The data ofHewitt and Blake (1968) for a slowgrowing syngeneic murine tumour
also appears to fit the Mayneord model. However, the rate ofgrowth of P-388
sarcoma in theimmunologically intact (incompatible) hostdependedlargely on the
size ofthechallenge dose and the effect ofthe latter on the rate at whichimmunity
to growth of tumour increased with time. Thus we prefer to analyse tumour
doubli-iigtime (T) in terms oftumoursize (W) ratherthan ageoftumour(t). T and
W werelinearlyrelated on alog-logplot, butTincreased morerapidlyiffewer cells
were inoculated. Since smallerinoculatakelongerthanlargerinocula to grow to a
tumour of the same mass, smaller inocula cause more prolonged stimulation of
immunological functions and cause a higher level ofimmunity to develop. For
lymph nodemetastases, T rose morerapidly than for theprimary tumour oforigin. This suggests that more efficient immunological defences develop in the node, but
sincethedisparityinsize betweenprimaryandsecondarytumourswouldalsoaffect
the efficacy of an immune reaction, this needs to be taken into account. WBI,
which suppresses earlyimmunological reactions to a tumour allograft to 'msi'gnifi-
cant proportions in the P-388 system and also in the Ehrlich tumour (van den
Brenk, 1961), causedgrowth ofboth theprimary P-388 tumour and its metastases
to approximate to an exponential rate of growth during the initial stages when
relativelylittle tumour necrosis had occurred. Thisfindingsuggests that immuno-
logicalincompatibilityplays asignificant andpossiblymajor role in causing curvi-
linear forms of tumour growth and increases in doubling times, particularly when
this is shownbyearly infiltrativegrowth ofsolid tumours such aspoorly differenti-
ated rat sarcomata. The nutrition made available by existing vasculature and206 H. A. S. VAN DEN BRENK ET AL.
stroma, even after the latter has been irradiated during whole body exposure of
570rad., appears adequate to support exponential rates ofgrowth for a time and
supportiveangiogenesis appears unnecessary tosupplement nutritiverequirements
at this stage. The factorsresponsible for linear rates oftumourgrowth, expressed
in terms of tumour dimensions with ageing, in syngeneic tumours, which show no
significantimmunologicalincompatibility (Hewitt andBlake, 1968) andpossibly in
spontaneous tumours, may be related to cell lossesresulting from cellular differen-
tiation and to the
" controlling
" effect imposed on tumour cell growth and
differentiation by the stimulation of stroma by a tumour as a co-ordinated
trophism. Pressure produced by expansive growth, particularly in more well
encapsulated tumours, may be another factor, but no satisfactory explanation
accounts for changes in growth rate of solid tumours, which encompasses cellular
kinetics, nutrition, immunity and a variety of other pathophysiological factors.
Indeed it seems rather remarkable that the many positive and negative factors
which interact to determine tumour growth rates allow any general quantitative
law of growth to be applicable. Some further difficulties clearly arise in inter-
preting curves of tumour growth after whole body irradiation ofrecipients. The
irradiation potentially both facilitates growth of tumour by inhibiting immunity
and restricts it by reducing the proliferative capacity of host tissues to provide a
nutritive stroma. For P-388 sarcoma the ratioM/P (mass ofmetastasis relative to
mass ofprimary) increased at alinear rate with tumour age. Thisrelationship was
independentofsize ofinoculum aindthe state ofimmunity. The rate ofincrease in
M/P was alsorelatively constant aiid was reducedonlybyinoculatingfewer cells in
immunologically intact animals when theimmunological reactions were efficient in
destroying less advancedgrowing tumour. Since rates ofincrease inM/P were the
same forgrowth oftumour in unirradiated ratsgivenlarge inocula as in irradiated
ratschallengedwitb few (ormany) cells, thissuggeststhatthe effects ofwholebody irradiation on the development and growth of metastases is limited to immuno-
logical effects. WBI does not appear to affect significantly other physiopatho- logical mechanisms, local orgeneral, associated with theproduction andgrowth of
metastases such as exfoliation, transfer, arrest and nutrition of cells in organs. Sublethal WBI causes marked metabolic changes associated with cellular destruc-
tion andotherphysiologicalchanges in organs andtissues, whichmightbeexpected
tomodifythegrowthofunirradiatedtumourcellsdepositedinthesetissues, but the
data obtained fail to support this view.
Theprogressive increase in immunityproduced bygrowth of tumour in the rat
enables unirradiated rats to survive with large and progressively growing primary tumours or with isolatedlargegrowing metastases, bydestroyingnewly deposited cells and thereby preventing other metastases developing. It also determines
survival of rats in which nodes may remain chronically enlarged due to the dual
presence ofnewly formed and growing and degenerating tumour foci. Similarly, animals which develop very large primaries may remain otherwise healthy and
appear free ofmetastases since ahighdegree ofimmunitydevelops whichprevents the establishment and growth of further metastases. Such clinical situations
not so different from those experienced from time to time in spontaneous human
cancer and its metastases-never occurred after immunological attenuation from
WBI. Experience with local irradiation oflargegrowingprimary tumours in rats
not pre-treated with WBI showed that such locally advanced tumours were
relatively readily cured by modest dosages (unpublished results; see also Fig. 1).GROWTH OF METASTASES FOLLOWING IRRADIATION 207
Furthermore, such local irradiation treatments did not reduceimmunity enhanced
bypreviousgrowth oftumour, since the incidence ofsubsequent metastasis did not
increase and the treated rats were subseqiiently shown to be resistant to further
challengesof 106or more P-388 cells.
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